Business Context and Reporting Period
Company: Inuvo, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2025
Reporting Period Covered: The filing references financial performance for the fourth quarter and full-year 2024, as well as a conference call discussing results for Q4 and full-year 2025 (noted as a potential discrepancy in the source text regarding the 2025 full-year reference).
Key Financial Metrics
This Form 8-K serves as a notification of the release of financial results rather than a detailed financial statement. Specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity are not provided within the text of this filing. The document states that these metrics are contained in the press release furnished as Exhibit 99.1 and the conference call script as Exhibit 99.2.
Material Changes and Corporate Governance
The filing details significant changes to the Board of Directors effective February 27, 2025:
- Departure: Charles Morgan retired immediately from his positions as Class III Director, Lead Independent Director, Chairman of the Nominating and Corporate Governance Committee, and member of the Audit Committee. His retirement was not due to any disagreement with the Company.
- Appointment: Rob Buchner was appointed as a Class III Director to fill the vacancy. His term expires at the 2026 annual meeting.
- Committee Assignments:
- Rob Buchner was appointed to the Nominating and Corporate Governance Committee.
- Kenneth E. Lee was appointed to the Audit Committee.
- Compensation: Mr. Buchner will receive an annual retainer of $30,000 in cash and 30,000 restricted stock units.
Guidance, Outlook, and Risks
The Company held a management conference call on February 27, 2025, to discuss financial results and the Company's outlook. The script for this call is attached as Exhibit 99.2. The filing notes that the press release includes non-GAAP financial information reconciled to GAAP measures. No specific risks, contingencies, or unusual items are detailed in the body of this 8-K text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2024 revenue, profit, and cash flow figures.
- Review Exhibit 99.2 (Conference Call Script) for management's detailed outlook and guidance for 2025.
- Verify the discrepancy in the text regarding the conference call discussing "full-year 2025" results, as the filing date is February 2025 (likely a typo for 2024 in the source text).
- Confirm the new Board composition and committee assignments effective immediately.